GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Precipio Inc (FRA:TGK) » Definitions » Shiller PE Ratio

Precipio (FRA:TGK) Shiller PE Ratio : (As of Jun. 09, 2024)


View and export this data going back to . Start your Free Trial

What is Precipio Shiller PE Ratio?

Note: If the price history is too short, we do not calculate current Shiller PE for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Precipio Shiller PE Ratio Historical Data

The historical data trend for Precipio's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precipio Shiller PE Ratio Chart

Precipio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Precipio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Precipio's Shiller PE Ratio

For the Diagnostics & Research subindustry, Precipio's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Precipio's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Precipio's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Precipio's Shiller PE Ratio falls into.



Precipio Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Precipio's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Precipio's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0/131.7762*131.7762
=0.000

Current CPI (Mar. 2024) = 131.7762.

Precipio Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -3,781.796 100.560 -4,955.779
201409 -364.729 100.428 -478.579
201412 -5,507.217 99.070 -7,325.349
201503 -2,993.778 99.621 -3,960.092
201506 -2,405.709 100.684 -3,148.619
201509 -4,410.468 100.392 -5,789.282
201512 -12,723.572 99.792 -16,801.520
201603 -1,454.769 100.470 -1,908.064
201606 -275.008 101.688 -356.379
201609 -307.393 101.861 -397.670
201612 -628.521 101.863 -813.096
201703 -474.042 102.862 -607.293
201706 -4,098.432 103.349 -5,225.743
201709 -342.310 104.136 -433.169
201712 -332.998 104.011 -421.890
201803 -115.162 105.290 -144.132
201806 -39.205 106.317 -48.593
201809 -42.679 106.507 -52.805
201812 -61.882 105.998 -76.931
201903 -8.496 107.251 -10.439
201906 -18.585 108.070 -22.662
201909 -5.630 108.329 -6.849
201912 -8.640 108.420 -10.501
202003 -14.118 108.902 -17.083
202006 -3.552 108.767 -4.303
202009 -3.566 109.815 -4.279
202012 -1.748 109.897 -2.096
202103 -1.344 111.754 -1.585
202106 -2.324 114.631 -2.672
202109 -1.360 115.734 -1.549
202112 -1.593 117.630 -1.785
202203 -3.632 121.301 -3.946
202206 -1.703 125.017 -1.795
202209 -2.818 125.227 -2.965
202212 -1.964 125.222 -2.067
202303 -2.428 127.348 -2.512
202306 -1.661 128.729 -1.700
202309 -0.974 129.860 -0.988
202312 0.000 129.419 0.000
202403 0.000 131.776 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Precipio  (FRA:TGK) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Precipio Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Precipio's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Precipio (FRA:TGK) Business Description

Traded in Other Exchanges
Address
4 Science Park, New Haven, CT, USA, 06511
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings.

Precipio (FRA:TGK) Headlines

No Headlines